QUOTE AND NEWS
PR Newswire  May 15  Comment 
VANCOUVER, May 15, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the first quarter ended March 31, 2012. Angiotech will host a conference call discussing its first quarter
PR Newswire  Apr 30  Comment 
First Quarter 2012 Financial Results VANCOUVER, April 30, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the first quarter ended March 31, 2012, on Tuesday, May 15, 2012 at 1:00 PM
PR Newswire  Apr 5  Comment 
Angiotech to Receive Initial Cash Consideration of $20 Million and Up to $42 Million in Potential Contingent Consideration Angiotech to Retain Rights to Manufacture, Market and Sell Quill VANCOUVER, April 4, 2012 /PRNewswire/ - Angiotech
PR Newswire  Mar 30  Comment 
VANCOUVER, March 30, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the fourth quarter ended December 31, 2011. Angiotech also announced that it implemented certain additional
PR Newswire  Mar 2  Comment 
Fourth Quarter and Year End 2011 Financial Results VANCOUVER, March 2, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2011, on
The Globe and Mail  Oct 21  Comment 
Company says Thomas Bailey replaces William Hunter on interim basis
The Globe and Mail  Oct 21  Comment 
Canadian Business  Apr 7  Comment 
VANCOUVER - Angiotech Pharmaceuticals Inc. says the Supreme Court of British Columbia has approved the Vancouver medical devices company's second
The Globe and Mail  Apr 5  Comment 
Proposal to go before B.C. court on Wednesday
Canadian Business  Feb 2  Comment 
VANCOUVER - Angiotech Pharmaceuticals Inc. (TSX:ANP) says it will delist from the Toronto Stock Exchange next month after failing to meet
Penny Stock DD  Feb 2  Comment 
Icagen, Inc. (NASDAQ:ICGN) move up by 12.54% to close at $3.41 with overall traded volume of 1.47 million shares in the last trading day as compare to its average volume stood at 534.75k shares. The RSI value of 72.43 times depicts that the...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki